Clinical Trial Detail

NCT ID NCT03774472
Title Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Participants With Estrogen Receptor Positive, HER2 Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Hydroxychloroquine + Letrozole + Palbociclib

Age Groups: senior adult

Additional content available in CKB BOOST